Related Experiment Video

Updated: May 8, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children

H Sano1, R Kobayashi1, A Iguchi2

  • 1Department of Pediatrics, Sapporo Hokuyu Hospital, Sapporo, Japan.

Bone Marrow Transplantation
|August 20, 2013
PubMed

Insights

Idiopathic pneumonia syndrome (IPS) is a serious complication after pediatric allogeneic hematopoietic stem cell transplantation (HSCT). Prior HSCT and acute GVHD (grade II-IV) are key risk factors for developing IPS.

Area of Science:

  • Pediatric Hematology
  • Transplantation Immunology
  • Pulmonary Medicine

Background:

  • Idiopathic pneumonia syndrome (IPS) is a life-threatening complication post-allogeneic hematopoietic stem cell transplantation (HSCT).
  • Limited data exists on IPS risk factors specifically in pediatric populations undergoing HSCT.

Purpose of the Study:

  • To determine the incidence of IPS in children undergoing allogeneic HSCT.
  • To identify significant risk factors associated with IPS development in this cohort.

Main Methods:

  • Retrospective analysis of 210 pediatric patients (hematologic malignancies, aplastic anemia, solid tumors) undergoing allogeneic HSCT.
  • Comparison of patient and transplantation characteristics between patients who developed IPS and those who did not.
  • Multivariate analysis to confirm independent risk factors for IPS.

Main Results:

  • The cumulative incidence of IPS within 120 days post-HSCT was 6.7% (14/210).
  • Patients with IPS had a significantly higher frequency of prior HSCT (35.7% vs. 12.8%, P=0.018).
  • Acute GVHD (grade II-IV) was more prevalent in the IPS group (50.0% vs. 18.9%, P=0.006).
  • Mortality following IPS was high, with 11 of 14 patients (78.6%) dying.

Conclusions:

  • Prior HSCT and acute GVHD (grade II-IV) are significant independent risk factors for IPS in pediatric allogeneic HSCT recipients.
  • Awareness of these risk factors is crucial for early detection and management of IPS.
  • The high mortality rate underscores the critical nature of IPS following pediatric HSCT.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: